Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

The substantial strain placed on health care workers and organizations by unnecessary ED visits prompted Orlando Health Cancer Institute to develop their express symptom management program in July 2021. The program was designed to effectively triage and treat cancer related symptoms in the outpatient setting.
Working under the hypothesis that a subset of de novo oligometastatic breast cancer patients who are treated with a combination of systemic therapy, surgery, and radiation or ablation of metastatic sites will have long-term distant metastasis free and overall survival, this multi-cohort, prospective, nationwide registry study will enroll newly diagnosed oligometastatic HER2+ breast cancer …
June 14, 2023
This is an opportunity to meet with oncology colleagues in an informal setting to discuss treatment strategies and recent clinical data around case-based profiles in the areas of lung cancer and multiple myeloma. You choose the topic that is best aligned for the patients you're seeing in your practice now. Our moderators will present case-based clinical profiles to generate discussion among participants …
Developing a Health Literacy and Clear Communications e-Course 1 ASSOCIATION OF COMMUNITY CANCER CENTERS accc-cancer.org/early-NSCLC OVERVIEW OF EARLY STAGE NON-SMALL CELL LUNG CANCER SURVEY RESULTS ASSOCIATION OF COMMUNITY CANCER CENTERS ACCC conducted a survey of multidisciplinary providers across the United States to assess current diagnostic, staging, and treatment practices …
National Black Family Cancer Awareness Week is dedicated to raising awareness of the importance of clinical trial participation and specimen donations for cancer research among Black Americans.
The Association of Community Cancer Centers (ACCC) is highly concerned about the ongoing shortages of platinum-based chemotherapy agents (e.g., cisplatin and carboplatin), two medications that (individually or in combination) treat and cure a wide range of cancers, including but not limited to gastric, pancreatic, colorectal, esophageal, cervical, and ovarian.
June 14, 2023
Value-Based Care Best Practices for Oncology Programs and Practices We now know that value-based care is here to stay. So what do cancer programs and practices need to do in order to effectively prepare and implement an alternative payment model? Panelists will share best practices when developing and implementing an alternative payment model, including how you can maintain person-centered care in …
PowerPoint Presentation June 8, 2023 TxSCO Update Overview: Notable Updates 2 Federal • In-office dispensers and mail order drugs • Site neutral payment provision advances to House floor • Merck files lawsuit challenging IRA • EOM: the latest State • Updated Medicaid unwinding estimates and state survey responses • Legislative Update • Budget …
Scan the QR code with your smartphone or visit the link below to explore this program. The ASCO Direct™ Highlights program reviews practice-changing data and other “hot topics” discussed at the premier clinical oncology conference in North America, including information about hematologic malignancies and thoracic, breast, gastrointestinal, genitourinary, gynecologic, and dermatologic …
6/12/23, 1:22 PM Association of Community Cancer Centers https://forms.accc-cancer.org/acton/rif/43296/s-0d63-2306/-/l-7f77:1/l-7f77/showPreparedMessage?utm_term=View&utm_campaign=ACCC NOC&utm… 1/3 View in Browser Registration is now open! Reimagine how your team works together to deliver value-based quality care— and a better patient experience—and develop creative solutions to address …
Subject Line: Your June Oncology Newsletter Is Here! Pre-Header: Review June Drug Updates & Upcoming Area Meetings NCOA Logo Header Your Oncology Newsletter: June 2023 edition has arrived! This monthly digital publication—a benefit of NCOA membership—features updated and accurate information on newly approved medications, indications, and changes in administration. Download your copy …
ACCC is announcing the release of a suite of powerful case studies from member institutions that highlight innovations to remove barriers and streamline precision medicine workflows.
PowerPoint Presentation June 8, 2023 TxSCO Update Overview: Notable Updates 2 Federal • In-office dispensers and mail order drugs • Site neutral payment provision advances to House floor • Merck files lawsuit challenging IRA • EOM: the latest State • Updated Medicaid unwinding estimates and state survey responses • Legislative Update • Budget …
Let’s Win Pancreatic Cancer is an advocacy organization that works with patients, providers, and researchers to share the latest information and treatment options for pancreatic cancer.
Corporate Membership Terms and Conditions 2024 1 OVERVIEW: Missouri Oncology Society (MOS) is a member of The Oncology State Societies at ACCC, a network of 23 State Chapters that are managed by—and collaborate with—the Association of Community Cancer Centers (ACCC) and are members of the American Society of Clinical Oncology State/Regional Affiliate Program. State Societies within …
QUESTIONS? Registration: btregistration@spargoinc.com Hotel Reservation: bthousing@spargoinc.com Phone: 888-788-1522 (within the U.S.) or +1-703-449-6418 (outside the U.S.) Hours of Operation: 8:30 AM–5:00 PM (ET) REGISTRATION AND HOTEL RESERVATIONS asco.org/btregister HOTEL RESERVATION AND EARLY REGISTRATION DEADLINE June 28, 2023, at 11:59 PM (ET) Am er ic an …
TACOS Tuesdays 2023
June is Cancer Immunotherapy Month, and ACCC is highlighting the important work that it and its partners are doing to increase patient access to these novel therapies.
Rockville, MD – The treatment of patients with Chronic Lymphocytic Leukemia (CLL) has shifted substantially in the past five years from intravenous treatments (IV) to oral oncolytics. With this transition towards oral therapies, cancer care teams face different challenges such as medication adherence, polypharmacy, financial toxicity, and interruptions in continuity of care due to oral prescriptions …
As biomarker testing can play a critical role in the diagnosis of rare cancers, such as NTRK gene fusion-positive cancers, hear what care teams need to know about identifying patients who may be eligible for this testing.